Relationship between nutritional biomarkers and occlusal status in gastric cancer patients using the Eichner index: Observational study.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
18 Mar 2022
18 Mar 2022
Historique:
received:
01
12
2020
received:
16
01
2022
accepted:
24
02
2022
entrez:
31
3
2022
pubmed:
1
4
2022
medline:
7
4
2022
Statut:
ppublish
Résumé
Systemic inflammatory responses and nutritional status are useful prognostic factors in gastric cancer patients. Since oral hypofunction causes undernutrition, we cross-sectionally investigated whether nutritional biomarkers were affected by the occlusal supporting zone status.In 114 gastric cancer patients, the gastric cancer stage, body mass index, albumin levels, total lymphocyte counts, cholesterol levels, C-reactive protein levels, and 4 nutritional biomarkers - the Glasgow prognostic score (GPS), neutrophil-lymphocyte ratio, prognostic nutrition index (PNI), and controlling nutritional status (CONUT) - were evaluated. Oral conditions were assessed by determining the number of remaining teeth. The occlusal supporting status was based on the Eichner classification. Patients were assigned into 3 groups per their occlusal status, and mean values were compared using the Kruskal-Wallis test. The mean age and body mass index were 72.2 ± 8.5 (50-89) years and 22.0 ± 3.6 (14.8-33.4), respectively. There were 42, 39, 23, and 10 patients in stages I, II, III, and IV, respectively. The mean number of remaining teeth was 18.1 ± 9.5. According to the Eichner classification, there were 45, 42, and 27 patients in groups A, B, and C, respectively. The GPS and neutrophil-lymphocyte ratio values and CONUT frequencies between groups A and C were significantly different (P = .033, P = .00097, P = .04, respectively; Mann-Whitney U test). PNI values were lower in group C with poor occlusal support zones than in group A with stable occlusal support zones.Occlusal supporting zone reductions were undernutrition associated. Eichner Class C patients with few occlusal supporting zones had poor GPS, PNI, and CONUT values and were undernourished.
Identifiants
pubmed: 35356942
doi: 10.1097/MD.0000000000029094
pii: 00005792-202203180-00045
pmc: PMC10684134
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interest to disclose.
Références
Surg Today. 2018 Apr;48(4):388-394
pubmed: 29043453
PLoS One. 2014 Nov 06;9(11):e112361
pubmed: 25375150
Cancer Res. 2009 Jul 1;69(13):5383-91
pubmed: 19549917
Gerodontology. 2005 Dec;22(4):234-7
pubmed: 16329232
Ann Surg Oncol. 2016 Mar;23(3):900-7
pubmed: 26530445
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Lancet Oncol. 2014 Oct;15(11):e493-503
pubmed: 25281468
J Dent Res. 2010 May;89(5):462-7
pubmed: 20207704
Community Dent Oral Epidemiol. 2010 Feb;38(1):43-9
pubmed: 19922495
Cancer Manag Res. 2018 Dec 05;10:6677-6683
pubmed: 30584362
J Dent Res. 2003 Feb;82(2):123-6
pubmed: 12562885
Nihon Geka Gakkai Zasshi. 1988 May;89(5):671-83
pubmed: 3166103
Cancer Treat Rev. 2015 Dec;41(10):971-8
pubmed: 26481060
BMC Cancer. 2018 Aug 13;18(1):816
pubmed: 30103707
Br J Cancer. 2004 May 4;90(9):1704-6
pubmed: 15150622
Nutr Hosp. 2012 Mar-Apr;27(2):564-71
pubmed: 22732985
J Nutr Health Aging. 2006 Nov-Dec;10(6):495-499; discussion 500-501
pubmed: 17183421
Cancer Res. 2011 Apr 1;71(7):2411-6
pubmed: 21427354
Nutr Cancer. 2002;42(2):191-3
pubmed: 12416259
Br J Surg. 2010 Jan;97(1):92-7
pubmed: 20013933
Colorectal Dis. 2016 Jul;18(7):O236-42
pubmed: 27154050
Crit Rev Oral Biol Med. 2002;13(3):291-300
pubmed: 12090466
Br J Cancer. 2014 Mar 18;110(6):1409-12
pubmed: 24548867
Nutr Res. 2017 Dec;48:1-8
pubmed: 29246276
J Prosthet Dent. 1997 Jun;77(6):588-95
pubmed: 9185051
Onco Targets Ther. 2016 Jun 27;9:3883-91
pubmed: 27390529
Curr Opin Clin Nutr Metab Care. 2009 May;12(3):223-6
pubmed: 19318937
Onco Targets Ther. 2015 Jan 08;8:137-45
pubmed: 25609981
Arch Oral Biol. 2011 Oct;56(10):991-6
pubmed: 21529776
Oral Dis. 2004 Jan;10(1):44-9
pubmed: 14996294
Lancet Oncol. 2013 Nov;14(12):e535-47
pubmed: 24176572
Cancer Treat Rev. 2014 Jul;40(6):685-91
pubmed: 24321611
Nutr Hosp. 2005 Jan-Feb;20(1):38-45
pubmed: 15762418
Cell Death Differ. 2005 Apr;12(4):317-25
pubmed: 15678149
Gastric Cancer. 2019 Jul;22(4):684-691
pubmed: 30417313
Gastric Cancer. 2010 Aug;13(3):170-6
pubmed: 20820986
Proc Nutr Soc. 2008 Aug;67(3):257-62
pubmed: 18452641
J Surg Oncol. 2011 Dec;104(7):734-40
pubmed: 21792945
Br J Cancer. 2012 Aug 7;107(4):695-9
pubmed: 22828611
Br J Surg. 2010 Jul;97(7):1035-42
pubmed: 20632269
J Oral Maxillofac Surg. 2013 Nov;71(11):1853-60
pubmed: 23845698
Br J Cancer. 2012 Sep 4;107(6):988-93
pubmed: 22878374
Int J Exp Pathol. 2009 Jun;90(3):222-31
pubmed: 19563607
Eur J Surg Oncol. 2016 Aug;42(8):1176-82
pubmed: 27293109
Cancer Treat Rev. 2013 Aug;39(5):534-40
pubmed: 22995477
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Nutrition. 2008 Jun;24(6):546-53
pubmed: 18455655
BMC Oral Health. 2019 Jun 13;19(1):110
pubmed: 31196057